These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 862343)

  • 21. [Recent aspects on regulation of calcium metabolism. I. Vitamin D].
    Nielsen SP
    Ugeskr Laeger; 1973 Nov; 135(46):2504-7. PubMed ID: 4361021
    [No Abstract]   [Full Text] [Related]  

  • 22. [Osteomalacia in the adult].
    Bregeon C; Bernat M
    Sem Hop; 1974 Sep 10-20; 50(37-38):2331-5. PubMed ID: 4375306
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of vitamin D in renal bone disease.
    Stanbury SW
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():25s-30s. PubMed ID: 342146
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical significance of vitamin D metabolites].
    Araszkiewicz Z
    Pol Arch Med Wewn; 1975 Oct; 54(4):387-93. PubMed ID: 1187406
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirements of vitamin D metabolites in patients with renal disease.
    Massry SG
    Am J Clin Nutr; 1980 Jul; 33(7):1530-5. PubMed ID: 6893103
    [No Abstract]   [Full Text] [Related]  

  • 27. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteomalacia and celiac disease: response to 25-hydroxyvitamin D.
    Hepner GW; Jowsey J; Arnaud C; Gordon S; Black J; Roginsky M; Moo HF; Young JF
    Am J Med; 1978 Dec; 65(6):1015-20. PubMed ID: 742623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
    Brickman AS; Norman AW
    Kidney Int; 1973 Aug; 4(2):161-7. PubMed ID: 4364427
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral 25-hydroxyvitain D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy.
    Compston JE; Horton LW
    Gastroenterology; 1978 May; 74(5 Pt 1):900-2. PubMed ID: 640344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 32. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.
    Fournier A; Morinière PH; Oprisiu R; Yverneau-Hardy P; Westeel PF; Mazouz H; el Esper N; Ghazali A; Boudailliez B
    Nephron; 1995; 71(3):254-83. PubMed ID: 8569975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of adult onset hypophosphatemic vitamin D resistant osteomalacia].
    Katagiri T; Suzuki T; Akiyama Y; Ishibashi T; Hara K; Oka H; Imai T; Kobayashi K; Kitagawa H; Ohno S
    Ryumachi; 1992 Oct; 32(5):461-7; discussion 466-7. PubMed ID: 1440082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma vitamin D metabolites in a patient with sporadic hypophosphataemic osteomalacia (adult-onset type).
    Ulmann A; Bouchard P; Garabédian M; Bourdeau A; Witmer-Cournot G; Lacour B; Balsan S; Funck-Brentano JL
    Eur J Clin Invest; 1980 Oct; 10(5):369-72. PubMed ID: 6777170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intestinal absorption of phosphorus. Its relation to calcium absorption and to treatment with vitamin D in osteomalacia, parathyroid dysfunction and chronic renal failure.
    Stamp TC
    Clin Sci; 1972 Apr; 42(4):16P. PubMed ID: 5020269
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.
    Reed JS; Meredith SC; Nemchausky BA; Rosenberg IH; Boyer JL
    Gastroenterology; 1980 Mar; 78(3):512-7. PubMed ID: 7351289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ["Vitamin resistant" osteomalacia due to a defect in hepatic hydroxylation of vitamin D; reversible secondary-pseudo-hypoparathyroidism due to calcium administration].
    Renier JC; Boasson M; Bernat M; Basle M
    Sem Hop; 1977 Jul 10-20; 53(25-28):1523-9. PubMed ID: 197643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
    Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
    Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.